Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

155.96 +5.83 (+3.88%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Masimo is Executing a Successful Strategy to Deliver Long-Term, Sustainable Growth
From Masimo Corporation
Via Business Wire
Masimo W1® Medical Watch Receives FDA 510(k) Clearance for Connectivity to the Masimo SafetyNet® Telemonitoring System
From Masimo
Via Business Wire
MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
MASI Stock Earnings: Masimo Beats EPS, Beats Revenue for Q2 2024
MASI stock results show that Masimo beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Masimo Reports Second Quarter 2024 Financial Results
From Masimo Corporation
Via Business Wire
New Study Finds That Remote Patient Monitoring with Masimo SafetyNet® Significantly Reduced Rates of Hospital Readmission and ED Visits for Patients Recuperating at Home After Joint Replacement Surgery
From Masimo
Via Business Wire
Masimo to Report Second Quarter 2024 Financial Results After Market Close on Tuesday, August 6
From Masimo
Via Business Wire
Lowey Dannenberg, P.C. is Investigating Masimo Corporation (NASDAQ: MASI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
3 Healthcare Stocks to Buy Now: Q3 Edition
U.S. healthcare expenditures will grow by 5.6% annually, presenting a revenue tailwind for these healthcare stocks to buy now. 
Via InvestorPlace
Politan Comments on Masimo’s Latest Entrenchment Maneuvers
From Politan Capital Management
Via Business Wire
Masimo Files Complaint Seeking Injunction Requiring Politan to Correct Material Misstatements
From Masimo Corporation
Via Business Wire
Leading Proxy Advisory Firm ISS Recommends Masimo Shareholders Vote FOR Both of Politan’s Director Nominees
From Politan Capital Management
Via Business Wire
Masimo Responds to Politan’s Continuing Misrepresentations
From Masimo Corporation
Via Business Wire
Leading Proxy Advisory Firm Glass Lewis Recommends Masimo Shareholders Vote FOR Both of Politan’s Director Nominees
From Politan Capital Management
Via Business Wire
Masimo Independent Director Michelle Brennan Encourages Shareholders to Support an Urgently Needed Cultural Reset in the Company’s Boardroom
From Politan Capital Management
Via Business Wire
Masimo Exposes Politan’s Governance Hypocrisy
From Masimo Corporation
Via Business Wire
What's Going On With Health Technology Company Masimo Shares Today?
Masimo reportedly considers an $850 million to $950 million bid for its consumer business amid active joint venture discussions while reporting strong Q2 healthcare revenue growth and record customer... 
Via Benzinga
Masimo Announces Preliminary Second Quarter 2024 Revenue and Select Financial Results
From Masimo Corporation
Via Business Wire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation – MASI
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation – MASI
From The Rosen Law Firm PA
Via GlobeNewswire
Masimo Provides Facts, Exposes False Narratives in Response to Latest Politan Fictions
From Masimo Corporation
Via Business Wire
Lowey Dannenberg, P.C. is Investigating Masimo Corporation (NASDAQ: MASI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Masimo Nominee Christopher Chavez Would Bring Fierce Independence, Exemplary Medtech CEO Experience to Masimo Board
From Masimo Corporation
Via Business Wire
Masimo Announces Sleep Halo™, Advanced Sleep Analysis for the Masimo W1®
From Masimo
Via Business Wire
Lowey Dannenberg, P.C. is Investigating Masimo Corporation (NASDAQ: MASI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Masimo and Cleveland Clinic Collaborate to Improve Hospital Remote Care
From Masimo
Via Business Wire
Masimo Files Investor Presentation Highlighting Innovation-Driven Value, Strategic Initiatives to Deliver Robust Growth and Margin Expansion and Risks of Ceding Control to Politan
From Masimo Corporation
Via Business Wire
Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company’s Full Potential
From Politan Capital Management
Via Business Wire
Lowey Dannenberg, P.C. is Investigating Masimo Corporation (NASDAQ: MASI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation – MASI
From The Rosen Law Firm PA
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.